NASDAQ:NUWE Nuwellis (NUWE) Stock Price, News & Analysis → Top 5 Tech Stocks to Buy for 2024 (From Daily Market Alerts) (Ad) Free NUWE Stock Alerts $0.21 -0.01 (-4.52%) (As of 06/7/2024 ET) Add Compare Share Share Today's Range$0.20▼$0.2350-Day Range$0.13▼$0.3952-Week Range$0.13▼$3.83Volume1.33 million shsAverage Volume2.77 million shsMarket Capitalization$3.81 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends Get Nuwellis alerts: Email Address Ad Paradigm PressMillionaire-Making “Wealth Pattern” Just Repeated on April 22If you think you missed out on the Bitcoin band wagon… You need to watch this immediately.This Crypto bull market is not even halfway over About Nuwellis Stock (NASDAQ:NUWE)Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors primarily in Austria, Brazil, Colombia, the Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Panama. Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.Read More NUWE Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NUWE Stock News HeadlinesJune 6 at 9:00 AM | globenewswire.comNuwellis and DaVita Extend Supply and Collaboration Agreement Pilot PhaseMay 29, 2024 | americanbankingnews.comNuwellis, Inc. (NASDAQ:NUWE) Sees Large Decline in Short InterestMay 14, 2024 | finance.yahoo.comNuwellis Announces Expansion of Ultrafiltration Program to Pediatric Patients at One of the Largest Hospital Networks in FloridaMay 13, 2024 | msn.comNuwellis, Inc. (NASDAQ:NUWE) Q1 2024 Earnings Call TranscriptMay 9, 2024 | uk.finance.yahoo.comNuwellis Inc (NUWE) Q1 2024 Earnings Call Transcript Highlights: Strategic Adjustments and ...May 9, 2024 | uk.finance.yahoo.comQ1 2024 Nuwellis Inc Earnings CallMay 9, 2024 | msn.com3 Penny Stocks to Watch NowMay 9, 2024 | globenewswire.comNuwellis Announces Purchase Agreement with a 50 Hospital Network for Aquadex Ultrafiltration TherapyMay 7, 2024 | finance.yahoo.comNuwellis, Inc. Announces First Quarter 2024 Financial ResultsMay 7, 2024 | markets.businessinsider.comWhat Wall Street expects from Nuwellis's earningsMay 3, 2024 | msn.comU.S. shares higher at close of trade; Dow Jones Industrial Average up 0.85%May 2, 2024 | finance.yahoo.comNuwellis Receives USPTO Notice of Patent Allowance for Innovative Pediatric CRRT TechnologyApril 30, 2024 | globenewswire.comNuwellis Announces Closing of $2.7 Million Public OfferingApril 30, 2024 | globenewswire.comNuwellis, Inc. To Report First Quarter 2024 Financial Results on May 7, 2024April 26, 2024 | msn.comDow Surges Over 200 Points; Microsoft Shares Gain Following Upbeat EarningsApril 26, 2024 | msn.comUS Stocks Higher Following PCE Inflation Data; Nasdaq Jumps Over 200 PointsApril 26, 2024 | globenewswire.comNuwellis Announces Pricing of $2.7 Million Public OfferingApril 9, 2024 | finance.yahoo.comNuwellis Announces Launch of Ultrafiltration Therapy Using Aquadex Smartflow® System at Henry Ford HealthMarch 28, 2024 | finance.yahoo.comChildren's Minnesota Foundation Board of Directors adds six new membersMarch 12, 2024 | markets.businessinsider.comMaxim Group Keeps Their Buy Rating on Nuwellis (NUWE)March 8, 2024 | finance.yahoo.comNuwellis Full Year 2023 Earnings: EPS Beats ExpectationsMarch 7, 2024 | seekingalpha.comNuwellis, Inc. (NUWE) Q4 2023 Earnings Call TranscriptMarch 7, 2024 | finance.yahoo.comNuwellis, Inc. (NASDAQ:NUWE) Q4 2023 Earnings Call TranscriptMarch 7, 2024 | globenewswire.comLate-Breaking Data Highlighting Benefits of Ultrafiltration Therapy Using the Aquadex System for Heart Failure Patients was Presented at the Technology and Heart Failure Therapeutics ConferenceMarch 6, 2024 | nz.finance.yahoo.comNuwellis, Inc. (NUWE) stock price, news, quote & history – Yahoo FinanceSee More Headlines Receive NUWE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Nuwellis and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/07/2024Today6/07/2024Next Earnings (Estimated)8/13/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Electromedical equipment Sub-IndustryN/A Current SymbolNASDAQ:NUWE CUSIPN/A CIK1506492 Webwww.nuwellis.com Phone(952) 345-4200FaxN/AEmployees59Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($8.30) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-20,210,000.00 Net Margins-202.97% Pretax Margin-202.88% Return on Equity-316.90% Return on Assets-166.33% Debt Debt-to-Equity RatioN/A Current Ratio1.20 Quick Ratio0.71 Sales & Book Value Annual Sales$8.86 million Price / Sales0.43 Cash FlowN/A Price / Cash FlowN/A Book Value$0.53 per share Price / Book0.40Miscellaneous Outstanding Shares18,050,000Free Float17,582,000Market Cap$3.81 million OptionableNot Optionable Beta0.49 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Nestor Jaramillo Jr. (Age 67)President, CEO & Director Comp: $437.71kMr. Robert B. Scott (Age 44)Chief Financial Officer Comp: $252.6kMr. Neil P. Ayotte Esq. (Age 60)Senior VP, General Counsel, Secretary & Chief Compliance Officer Comp: $342.54kMr. John KowalczykSenior Vice President of Sales & MarketingMs. Sandra EayrsChief Human Resources OfficerMr. Vitaliy Epshteyn (Age 46)Sr. Vice President of Operations & Engineering Dr. John Lynn Jefferies FACCM.D., M.P.H., Chief Medical Officer & Member of Medical Advisory BoardMr. Paul Wotta (Age 67)Corporate Controller More ExecutivesKey CompetitorsSTRATA Skin SciencesNASDAQ:SSKNQT ImagingNASDAQ:QTIStar EquityNASDAQ:STRRGigCapital5NYSE:GIANexalin TechnologyNASDAQ:NXLView All Competitors NUWE Stock Analysis - Frequently Asked Questions Should I buy or sell Nuwellis stock right now? 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Nuwellis in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" NUWE shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NUWE, but not buy additional shares or sell existing shares. View NUWE analyst ratings or view top-rated stocks. How have NUWE shares performed in 2024? Nuwellis' stock was trading at $0.5809 at the beginning of the year. Since then, NUWE shares have decreased by 63.7% and is now trading at $0.2110. View the best growth stocks for 2024 here. Are investors shorting Nuwellis? Nuwellis saw a decrease in short interest during the month of May. As of May 15th, there was short interest totaling 612,300 shares, a decrease of 41.7% from the April 30th total of 1,050,000 shares. Based on an average daily volume of 5,640,000 shares, the days-to-cover ratio is presently 0.1 days. Approximately 9.0% of the company's stock are short sold. View Nuwellis' Short Interest. When is Nuwellis' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 13th 2024. View our NUWE earnings forecast. How were Nuwellis' earnings last quarter? Nuwellis, Inc. (NASDAQ:NUWE) posted its earnings results on Tuesday, May, 7th. The company reported ($0.60) EPS for the quarter. The business earned $1.86 million during the quarter. Nuwellis had a negative trailing twelve-month return on equity of 316.90% and a negative net margin of 202.97%. When did Nuwellis' stock split? Nuwellis shares reverse split on the morning of Sunday, December 11th 2022. The 1-100 reverse split was announced on Sunday, December 11th 2022. The number of shares owned by shareholders was adjusted after the market closes on Sunday, December 11th 2022. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split. How do I buy shares of Nuwellis? Shares of NUWE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:NUWE) was last updated on 6/8/2024 by MarketBeat.com Staff From Our PartnersMillionaire-Making “Wealth Pattern” Just Repeated on April 22If you think you missed out on the Bitcoin band wagon… You need to watch this immediately.Paradigm Press | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredAI Hell Will Break Loose [June 30, 2024] …On June 30, 2024, AI will reach a critical tipping point… Whatever you do, make sure you prepare before Ju...Banyan Hill Publishing | SponsoredWas the Great Financial Crisis fun?The Great Financial Crisis, which actually started in the summer of 2007 and did not end until March of 2009, ...Brooks Enterprises | SponsoredShocking $16T Elon Musk Crypto LeakReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto mark...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nuwellis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nuwellis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.